Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients

Inclusion Criteria

• •Patients diagnosed as type 2 diabetes mellitus;
• •Patients who had the intima-media thickness (IMT) of carotid artery ≥1.1 mm in at least one side;
• •Patients who had results of aspartate aminotransferase, alanine aminotransferase, and serum creatinine no more than 1.5 times higher than the upper limit of normal;
• •Patients who had not cardio or cerebral vascular events within 3 months, including non-fatal myocardial infarction, stable and unstable angina pectoris, and non-fatal cerebral ischemic and hemorrhagic stroke;
• •Patients who had their systolic blood pressure \<160 mmHg, diastolic blood pressure \<100 mmHg, and glycated hemoglobin (HbA1c) \<8.0%;
• •Patients who had not taken any medications with antithrombotic and antiplatelet effect within 3 months;